Horizon Pharma plc Presents Data at EULAR 2018 Advancing the Understanding and Management of Uncontrolled Gout
June 15, 2018 05:45 ET
|
Horizon Pharma plc
-- New insights on the factors associated with tophi formation and total body disease burden of gout -- DUBLIN, Ireland, June 15, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP)...
Epidemiologic Study Findings Show 27 Percent Increase in Emergency Department Visits for Gout in the United States Over the Past Decade
June 14, 2018 04:50 ET
|
Horizon Pharma plc
AMSTERDAM, The Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- Results from a new study presented in an oral presentation at the Annual European Congress of Rheumatology (EULAR 2018) show a dramatic...
Horizon Pharma plc and the National Organization for Rare Disorders (NORD) Illustrate 35 years of Progress in Rare Disease at the Biotechnology Innovation Organization (BIO) International Convention
June 04, 2018 08:00 ET
|
Horizon Pharma plc
-- People can join the campaign by texting the word “RARE” to 56512, which generates a donation to NORD -- DUBLIN, Ireland, June 04, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) and...
Horizon Pharma plc to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
May 30, 2018 08:00 ET
|
Horizon Pharma plc
DUBLIN, Ireland, May 30, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on...
Horizon Pharma plc Named One of the Best Small and Medium Workplaces in Chicago by FORTUNE
May 22, 2018 10:15 ET
|
Horizon Pharma plc
DUBLIN, Ireland, May 22, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) today announced that it has been selected to FORTUNE and Great Place to Work’s 2018 “Best Workplaces in Chicago”...
Horizon Pharma plc Launches GoutRevealed.com to Spotlight the Journey and Stories of People Living with Uncontrolled Gout
May 22, 2018 09:00 ET
|
Horizon Pharma plc
DUBLIN, Ireland, May 22, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) today marked Gout Awareness Day with the launch of Gout Revealed, which was created to spotlight real-life stories...
Horizon Pharma plc Reports Strong First-Quarter 2018 Orphan and Rheumatology Net Sales Growth; Increases Full-Year 2018 Guidance and Announces New Company Operating Structure to Enhance Focus on Rare Diseases
May 09, 2018 07:00 ET
|
Horizon Pharma plc
-- First-Quarter 2018 Orphan and Rheumatology Net Sales of $172.2 Million Increased 11 Percent;Represented 77 Percent of Total Company Net Sales -- -- First-Quarter 2018 KRYSTEXXA Net Sales Growth of...
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of Additional Notices of Allowance With Claims Covering RAVICTI® (glycerol phenylbutyrate) Oral Liquid
May 08, 2018 08:00 ET
|
Horizon Pharma plc
- Will Represent the Eighth and Ninth U.S. Patents to be Listed in the Orange Book for RAVICTI - DUBLIN, Ireland, May 08, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP) today announced...
Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 04, 2018 08:00 ET
|
Horizon Pharma plc
DUBLIN, IRELAND, May 04, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) today announced that the compensation committee of its board of directors approved the grant on May 1, 2018 of...
Horizon Pharma plc Announces Sangita Iyer as a 2018 Healthcare Businesswomen’s Association Rising Star
May 03, 2018 08:00 ET
|
Horizon Pharma plc
DUBLIN, Ireland, May 03, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP) today announced that Sangita Iyer, director, financial planning and analysis, has been named a 2018 Healthcare...